| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a versatile compound that interacts with cyclin D, exhibiting a unique ability to disrupt its binding with cyclin-dependent kinases. This disruption alters the phosphorylation state of target proteins, influencing cell cycle progression. The compound's intricate molecular structure allows for specific hydrogen bonding and hydrophobic interactions, which modulate the stability of the cyclin D-CDK complex, ultimately affecting cellular signaling cascades and regulatory mechanisms. | ||||||
Hygrolidin | 83329-73-1 | sc-391768 sc-391768A sc-391768B sc-391768C | 1 mg 5 mg 10 mg 25 mg | $332.00 $1300.00 $1900.00 $3749.00 | ||
Hygrolidin is a distinctive compound that engages with cyclin D through selective binding, influencing its conformation and stability. This interaction alters the dynamics of cyclin-dependent kinase complexes, impacting downstream signaling pathways. The compound's unique functional groups facilitate specific electrostatic interactions and steric effects, enhancing its ability to modulate protein-protein interactions. Its kinetic profile reveals a nuanced approach to regulating cellular processes, showcasing its role in cellular homeostasis. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
PD 0332991 is a small molecule inhibitor that specifically targets cyclin-dependent kinases 4 and 6 (CDK4/6), which are critical regulators of the cell cycle. | ||||||
Abemaciclib | 1231929-97-7 | sc-507342 | 10 mg | $110.00 | ||
Abemaciclib is a CDK4/6 inhibitor that can be used as a monotherapy or in combination with other agents. | ||||||
N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine Methanesulfonate | 1231930-82-7 | sc-496536 | 2.5 mg | $398.00 | ||
Also known as Abemaciclib-derivative, LY2835219 is a potent and selective inhibitor of CDK4/6 and has shown potential in research studies for various cells and tissues. This chemical is also known as Abemaciclib methanesulfonate | ||||||
Aurora Kinase/Cdk Inhibitor | 443797-96-4 | sc-203829 | 5 mg | $440.00 | ||
JNJ-7706621 is an investigational CDK4/6 inhibitor that has shown activity in research studies. | ||||||
P276-00 | 920113-03-7 | sc-477932 | 1 mg | $380.00 | ||
P276-00 is a novel CDK inhibitor that targets multiple cyclin-dependent kinases, including CDK4 and CDK6. | ||||||
SNS-032 | 345627-80-7 | sc-364621 sc-364621A | 5 mg 10 mg | $169.00 $262.00 | ||
SNS-032 is a selective inhibitor of CDK2, CDK7, and CDK9, but it also exhibits activity against CDK4/6, showing potential as a cyclin D inhibitor. | ||||||